Stocks and Investing
Stocks and Investing
Wed, April 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mani Foroohar Maintained (BLUE) at Hold with Decreased Target to $8 on, Apr 6th, 2022
Mani Foroohar of SVB Leerink, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $10 to $8 on, Apr 6th, 2022.
Mani has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Mani's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022
These are the ratings of the 2 analyists that currently disagree with Mani
- Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $4 on, Monday, March 7th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022
Contributing Sources